The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 27, 2015

Filed:

Feb. 22, 2013
Applicants:

Syntaxin Ltd., Abingdon, Oxon, GB;

Allergan Inc., Irvine, CA (US);

Inventors:

Keith Foster, Abingdon, GB;

John Chaddock, Abingdon, GB;

Philip Marks, Abingdon, GB;

Patrick Stancombe, Abingdon, GB;

Kei Roger Aoki, Irvine, CA (US);

Joseph Francis, Irvine, CA (US);

Lance Steward, Irvine, CA (US);

Assignees:

Syntaxin, Ltd., Abingdon, GB;

Allergan, Inc., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C12N 9/96 (2006.01); A61K 47/48 (2006.01); C12N 9/50 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/96 (2013.01); A61K 47/48246 (2013.01); C12N 9/50 (2013.01); C07K 2319/01 (2013.01); C07K 2319/33 (2013.01); C07K 2319/50 (2013.01); A61K 38/00 (2013.01);
Abstract

A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a dynorphin Targeting Moiety that is capable of binding to a Binding Site on the nociceptive sensory afferent, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the dynorphin Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent. Nucleic acid sequences encoding the polypeptide fusion proteins, methods of preparing same and uses thereof are also described.


Find Patent Forward Citations

Loading…